Data consolidation by Confident Cannabis provides insights into the chemical analysis of particular strains from all around the nation.
An interview with Albert Gutierrez, CEO of MedPharm, discussing recent movements by the DEA to move forward with medical cannabis research.
The national conversation about cannabis has included strain types, cannabinoids, and terpenes, but little public discourse occurred regarding flavonoids.
If we’ve learned anything at all from the exploration and research advances in cannabis science over the last 30 years, it’s that THC and CBD were just the tip of the iceberg, and many minor cannabinoids are on the rise.
With the industry expanding and the demand for cannabis continues to grow, the need for STEM experience and knowledge grows with it.
To help launch our new research category, we reached out to Celeste Miranda of MACE Media to discuss her mission to give the FDA a reputable source for validated cannabis research.
